Response Biomedical Corp.
Jonathan Fong is a seasoned professional with extensive experience in quality assurance, regulatory affairs, and property maintenance. Currently serving as a Quality Assurance Associate at Response Biomedical Corp. since March 2022, Jonathan has also held multiple roles including Senior Consultant/Director at Regwire and Co-Founder of ProudlyBC, which promotes local businesses in British Columbia. Additional experience includes working as a Materials Specialist at LifeLabs, a Program Assistant at Indigenous Services Canada, and a Documentation Specialist at ICBC. Jonathan has a strong foundation in regulatory compliance from previous roles at Kripps Pharmacy Ltd. and holds a B.Sc in Food, Nutrition, and Health from The University of British Columbia.
Response Biomedical Corp.
Response Biomedical Corp. develops, manufactures and markets the RAMP® system, a rapid diagnostics platform that delivers lab quality performance for efficient patient management in acute care settings. RAMP® is a global leader in comprehensive acute care testing with a wide range of markers available including Troponin I, CK-MB, Myoglobin, NT-proBNP, D-dimer and Procalcitonin. For effective and efficient patient care, RAMP® tests aid in the diagnosis of Acute Myocardial Infarction, Heart Failure and Sepsis.